Related Experiment Video
Updated: Nov 28, 2025
07:51
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
6.2K
miR-129-5p Inhibits Bone Formation Through TCF4.
Chong Yin1, Ye Tian1, Yang Yu2
1Lab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, Research Center for Special Medicine and Health Systems Engineering, NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, China.
Frontiers in Cell and Developmental Biology
|November 26, 2020
Summary
MicroRNA-129-5p inhibits bone formation by targeting Tcf4 and the Wnt/β-catenin pathway. A novel inhibitor of miR-129-5p shows promise for treating osteoporosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoporosis is a prevalent bone disease with inadequate current therapies.
- MicroRNAs (miRNAs) are key regulators of biological processes, including bone formation.
- The role of miR-129-5p in bone formation is not well understood.
Purpose of the Study:
- To investigate the function and mechanism of miR-129-5p in osteoblast differentiation and bone formation.
- To explore miR-129-5p as a potential therapeutic target for osteoporosis.
Main Methods:
- Assessed miRNA expression in osteoporosis mouse models.
- Manipulated miR-129-5p levels in cell lines (MC3T3-E1) and mice.
- Investigated the Wnt/β-catenin pathway and identified Tcf4 as a target gene.
- Developed and tested a novel recombinant miR-129-5p inhibitor.
Main Results:
- miR-129-5p expression was altered in osteoporosis models and negatively correlated with osteoblast differentiation markers.
- Overexpression of miR-129-5p inhibited osteoblast differentiation and bone formation, while downregulation enhanced it.
- miR-129-5p targets Tcf4, inhibiting the Wnt/β-catenin pathway.
- A novel miR-129-5p inhibitor promoted osteoblast differentiation and ameliorated osteoporosis in mice.
Conclusions:
- miR-129-5p acts as an inhibitor of bone formation by targeting Tcf4 and suppressing the Wnt/β-catenin pathway.
- A novel recombinant miR-129-5p inhibitor demonstrates therapeutic potential for osteoporosis.
- This study reveals a new mechanism in osteogenic differentiation and offers novel strategies for skeletal disorder treatment.
Related Concept Videos
01:16TGF - β Signaling Pathway
9.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
01:17Hormones and Bone Tissue
3.4K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.4K
02:23Master Transcription Regulators
7.5K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K
01:24Bone Formation by Endochondral Ossification
7.4K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.4K
01:29Bone Formation by Intramembranous Ossification
9.3K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.3K
01:40Bone Remodeling
39.6K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.6K